REGENERX BIOPHARMACEUTICALS INC Annual Interest Expense in USD from 2011 to 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Regenerx Biopharmaceuticals Inc quarterly/annual Interest Expense history and growth rate from 2011 to 2022.
  • Regenerx Biopharmaceuticals Inc Interest Expense for the quarter ending March 31, 2023 was $80.3K, unchanged year-over-year.
  • Regenerx Biopharmaceuticals Inc Interest Expense for the twelve months ending March 31, 2023 was $326K, a 0.24% increase year-over-year.
  • Regenerx Biopharmaceuticals Inc annual Interest Expense for 2022 was $326K, a 0.24% increase from 2021.
  • Regenerx Biopharmaceuticals Inc annual Interest Expense for 2021 was $325K, a 39.7% increase from 2020.
  • Regenerx Biopharmaceuticals Inc annual Interest Expense for 2020 was $233K, a 51.6% increase from 2019.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Annual (USD)
Interest Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 $326K +$769 +0.24% Jan 1, 2022 Dec 31, 2022 10-K 2023-04-11
2021 $325K +$92.2K +39.7% Jan 1, 2021 Dec 31, 2021 10-K 2023-04-11
2020 $233K +$79.2K +51.6% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-30
2019 $153K +$66.1K +75.8% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-02
2018 $87.3K -$83.6K -48.9% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-20
2017 $171K -$2.47K -1.43% Jan 1, 2017 Dec 31, 2017 10-K 2019-03-29
2016 $173K +$472 +0.27% Jan 1, 2016 Dec 31, 2016 10-K 2018-03-29
2015 $173K -$10.6K -5.77% Jan 1, 2015 Dec 31, 2015 10-K 2017-03-29
2014 $183K +$82.5K +81.8% Jan 1, 2014 Dec 31, 2014 10-K 2016-04-11
2013 $101K +$95.2K +1672% Jan 1, 2013 Dec 31, 2013 10-K 2015-03-31
2012 $5.7K +$5.7K Jan 1, 2012 Dec 31, 2012 10-K 2014-04-04
2011 $0 Jan 1, 2011 Dec 31, 2011 10-K 2013-04-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.